SK
Siva Kumar Appukuttan Sukesini
About Siva Kumar Appukuttan Sukesini
Siva Kumar Appukuttan Sukesini has 19 years in corporate governance. Holds Managing Director role. Currently with 1 company, including Upform Pharmaceuticals Private Limited. Formerly with 2 companies, such as Amazing Research Laboratories Limited and Corwis Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Upform Pharmaceuticals Private Limited
U24299DL2021PTC391385
|
Managing Director | 28 Nov 2024 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Amazing Research Laboratories Limited
U99999DL1998PLC095297
|
Whole-Time Director | 29 Aug 2017 | 1998 | Active |
Corwis Pharmaceuticals Limited
U24230DL2006PLC147642
|
Whole-Time Director | 01 Apr 2007 | 2006 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Siva Kumar Appukuttan Sukesini
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Siva Kumar Appukuttan Sukesini
Siva Kumar Appukuttan Sukesini has 19 years in corporate governance. Holds Managing Director role. Currently with 1 company, including Upform Pharmaceuticals Private Limited. Formerly with 2 companies, such as Amazing Research Laboratories Limited and Corwis Pharmaceuticals Limited. Engaged in General Business. Contributes to corporate operations.
Siva Kumar Appukuttan Sukesini is associated with 1 company as Managing Director.
Siva Kumar Appukuttan Sukesini has expertise in General Business.
Siva Kumar Appukuttan Sukesini has 19 years in corporate governance.